<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Leukemia &#8211; London Connected</title>
	<atom:link href="https://ldnconnected.co.uk/tag/leukemia/feed/" rel="self" type="application/rss+xml" />
	<link>https://ldnconnected.co.uk</link>
	<description>Hopping Between Hubs</description>
	<lastBuildDate>Wed, 13 Nov 2019 11:58:28 +0000</lastBuildDate>
	<language>en-GB</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.8.11</generator>
	<item>
		<title>MediSieve Continues Growth Trajectory with Latest Award</title>
		<link>https://ldnconnected.co.uk/medisieve-continues-growth-trajectory-with-latest-award/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=medisieve-continues-growth-trajectory-with-latest-award</link>
		
		<dc:creator><![CDATA[pr@redheadpr.co.uk]]></dc:creator>
		<pubDate>Wed, 13 Nov 2019 11:58:28 +0000</pubDate>
				<category><![CDATA[Awards]]></category>
		<category><![CDATA[Business]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Techno]]></category>
		<category><![CDATA[beanstalks]]></category>
		<category><![CDATA[george frodsham]]></category>
		<category><![CDATA[Leukemia]]></category>
		<category><![CDATA[malaria]]></category>
		<category><![CDATA[medical]]></category>
		<category><![CDATA[medisieve]]></category>
		<category><![CDATA[medtech]]></category>
		<category><![CDATA[sepsis]]></category>
		<guid isPermaLink="false">https://ldnconnected.co.uk/?p=119987</guid>

					<description><![CDATA[Medical device company MediSieve Ltd, has been announced as a winner of the ‘Breakthrough Medical or Healthcare Device Award’ in the Beanstalks competition 2019.  Dr George Frodsham, founder and CEO of MediSieve said, “We were very pleased to receive this award in what was a very competitive line-up, which included some fantastic and innovative companies.”  MediSieve is the medical device company which is developing ‘magnetic blood filtration’. Their technology [&#8230;]]]></description>
		
		
		
			</item>
		<item>
		<title>MediSieve CEO Winner of BBSRC Innovator of the Year Award</title>
		<link>https://ldnconnected.co.uk/medisieve-ceo-winner-of-bbsrc-innovator-of-the-year-award/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=medisieve-ceo-winner-of-bbsrc-innovator-of-the-year-award</link>
		
		<dc:creator><![CDATA[pr@redheadpr.co.uk]]></dc:creator>
		<pubDate>Thu, 01 Aug 2019 17:31:12 +0000</pubDate>
				<category><![CDATA[Business]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[award]]></category>
		<category><![CDATA[BBRSC]]></category>
		<category><![CDATA[george frodsham]]></category>
		<category><![CDATA[Leukemia]]></category>
		<category><![CDATA[malaria]]></category>
		<category><![CDATA[medical]]></category>
		<category><![CDATA[medisieve]]></category>
		<category><![CDATA[medtech]]></category>
		<category><![CDATA[sepsis]]></category>
		<guid isPermaLink="false">https://ldnconnected.co.uk/?p=118231</guid>

					<description><![CDATA[Dr George Frodsham, founder and CEO at MediSieve, the medical device company developing ‘magnetic blood filtration’, has won the Early Career Impact Award at the BBSRC Innovator of the Year Awards 2019. The award was presented by Chris Skidmore MP, Minister of State for Universities, Science, Research and Innovation at a glamorous awards ceremony in [&#8230;]]]></description>
		
		
		
			</item>
		<item>
		<title>MediSieve magnetic blood filter is granted US patent</title>
		<link>https://ldnconnected.co.uk/medisieve-magnetic-blood-filter-is-granted-us-patent/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=medisieve-magnetic-blood-filter-is-granted-us-patent</link>
		
		<dc:creator><![CDATA[pr@redheadpr.co.uk]]></dc:creator>
		<pubDate>Sat, 15 Jun 2019 15:10:10 +0000</pubDate>
				<category><![CDATA[Awards]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[george frodsham]]></category>
		<category><![CDATA[Leukemia]]></category>
		<category><![CDATA[malaria]]></category>
		<category><![CDATA[medical]]></category>
		<category><![CDATA[medisieve]]></category>
		<category><![CDATA[medtech]]></category>
		<category><![CDATA[sepsis]]></category>
		<guid isPermaLink="false">https://ldnconnected.co.uk/?p=117019</guid>

					<description><![CDATA[Medical device company MediSieve Ltd, which has developed the concept of magnetic blood filtration to remove disease-causing agents from the blood, has been awarded a patent for its product in America. The technology can potentially transform the treatment of blood-borne diseases including sepsis, leukaemia and malaria in a process that’s similar to dialysis. The patent [&#8230;]]]></description>
		
		
		
			</item>
		<item>
		<title>MEDISIEVE PAVES WAY FOR GROWTH AND PRODUCT DEVELOPMENT WITH GRANTS FROM INNOVATE UK</title>
		<link>https://ldnconnected.co.uk/medisieve-paves-way-for-growth-and-product-development-with-grants-from-innovate-uk/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=medisieve-paves-way-for-growth-and-product-development-with-grants-from-innovate-uk</link>
		
		<dc:creator><![CDATA[pr@redheadpr.co.uk]]></dc:creator>
		<pubDate>Mon, 03 Jun 2019 19:00:10 +0000</pubDate>
				<category><![CDATA[Business]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[george frodsham]]></category>
		<category><![CDATA[Leukemia]]></category>
		<category><![CDATA[malaria]]></category>
		<category><![CDATA[medical]]></category>
		<category><![CDATA[medisieve]]></category>
		<category><![CDATA[medtech]]></category>
		<category><![CDATA[sepsis]]></category>
		<guid isPermaLink="false">https://ldnconnected.co.uk/?p=116869</guid>

					<description><![CDATA[Expands team to meet goals around developing Sepsis product After receiving two grants worth a total of £1.56m, MediSieve announces that the company has doubled in size since the start of the year, with the recruitment of three biochemists, a regulatory analyst and an immunologist, as well as expanding their office and laboratory space. MediSieve, [&#8230;]]]></description>
		
		
		
			</item>
		<item>
		<title>MediSieve raises awareness ahead of World Malaria Day</title>
		<link>https://ldnconnected.co.uk/medisieve-raises-awareness-ahead-of-world-malaria-day/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=medisieve-raises-awareness-ahead-of-world-malaria-day</link>
		
		<dc:creator><![CDATA[pr@redheadpr.co.uk]]></dc:creator>
		<pubDate>Fri, 08 Mar 2019 08:54:11 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[george frodsham]]></category>
		<category><![CDATA[Leukemia]]></category>
		<category><![CDATA[malaria]]></category>
		<category><![CDATA[medical]]></category>
		<category><![CDATA[medisieve]]></category>
		<category><![CDATA[medtech]]></category>
		<category><![CDATA[sepsis]]></category>
		<guid isPermaLink="false">https://ldnconnected.co.uk/?p=115482</guid>

					<description><![CDATA[Medical technology firm MediSieve Ltd is highlighting its work for World Malaria Day on April 25 &#8211; as figures show 435,000 people died from the disease in 2017.  Established in 2007, the yearly event celebrates efforts worldwide to control malaria. It’s marked by the World Health Organisation (WHO) and partner organisations. Most efforts focus on [&#8230;]]]></description>
		
		
		
			</item>
		<item>
		<title>MediSieve receive two grants, totalling £1.56M from Innovate UK</title>
		<link>https://ldnconnected.co.uk/medisieve-receive-two-grants-totalling-1-56m-from-innovate-uk/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=medisieve-receive-two-grants-totalling-1-56m-from-innovate-uk</link>
		
		<dc:creator><![CDATA[pr@redheadpr.co.uk]]></dc:creator>
		<pubDate>Thu, 31 Jan 2019 07:56:44 +0000</pubDate>
				<category><![CDATA[Business]]></category>
		<category><![CDATA[Awards]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[george frodsham]]></category>
		<category><![CDATA[Government]]></category>
		<category><![CDATA[grant]]></category>
		<category><![CDATA[Leukemia]]></category>
		<category><![CDATA[malaria]]></category>
		<category><![CDATA[medical]]></category>
		<category><![CDATA[medisieve]]></category>
		<category><![CDATA[medtech]]></category>
		<category><![CDATA[sepsis]]></category>
		<guid isPermaLink="false">https://ldnconnected.co.uk/?p=115128</guid>

					<description><![CDATA[MediSieve is delighted to announce that it is receiving two grants from Innovate UK, worth a total of around £1.56m. One large biomedical catalyst grant will progress development of a severe sepsis product, developing five magnetic particles to remove different sepsis targets. Another SRBI grant enables further focus on one of those particles and how [&#8230;]]]></description>
		
		
		
			</item>
	</channel>
</rss>
